BCL11A

From WikiMD's WELLNESSPEDIA

BCL11A is a gene that encodes a zinc finger protein and acts as a transcriptional repressor. It is involved in the development of the nervous system and hematopoiesis, the formation of blood cellular components.

Location of the BCL11A gene on chromosome 2.

Function[edit]

The BCL11A gene provides instructions for making a protein that is found in many tissues and cell types, but is most abundant in the brain and immune system cells. This protein is a transcription factor, which means it attaches (binds) to specific regions of DNA and helps control the activity of certain genes.

Role in Hemoglobin Switching[edit]

The BCL11A protein plays a critical role in the control of hemoglobin production. Hemoglobin is the protein in red blood cells that carries oxygen. Before birth, the developing fetus produces a form of hemoglobin known as fetal hemoglobin. After birth, the body switches to producing a different form of hemoglobin known as adult hemoglobin. The BCL11A protein helps control this switch by repressing the production of fetal hemoglobin and promoting the production of adult hemoglobin.

Clinical Significance[edit]

Mutations in the BCL11A gene have been associated with intellectual disability, autism, and seizures. In addition, variations in the BCL11A gene have been associated with persistent fetal hemoglobin (HPFH), a condition in which fetal hemoglobin production continues after birth. This condition can be beneficial for individuals with sickle cell disease or beta-thalassemia, as the presence of fetal hemoglobin can reduce the severity of these conditions.

Research[edit]

Research is ongoing to understand the role of BCL11A in health and disease. Some studies are investigating the possibility of using BCL11A as a therapeutic target for treating sickle cell disease and beta-thalassemia. By inhibiting the function of BCL11A, it may be possible to increase the production of fetal hemoglobin and reduce the symptoms of these diseases.

See Also[edit]

References[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.